Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

View source ↗

Summary

A clinical trial update evaluating a block-and-replace strategy using Osilodrostat with concurrent glucocorticoid replacement for endogenous Cushing syndrome wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osilodrostat (osilodrostat)

Snippet

Sponsor: University of Michigan | Conditions: Endogenous Cushing Syndrome, Adrenal Insufficiency | Status: RECRUITING